Boston Scientific warns cybersecurity outage may lead to missed guidance
Boston Scientific shares fell after the company said a cybersecurity incident will likely prevent it from meeting full-year guidance. It lowered its full-year sales growth outlook to 5.5%–6.5% and reduced adjusted EPS to $3.28–$3.22. The company is restoring affected systems, and major distribution centers are shipping at or near normal levels, though full operational and revenue impacts remain uncertain.